LD-2 disclosure · 3rd Quarter - Report
MT PHARMA AMERICA, INC.
Client
- Name
- MT PHARMA AMERICA, INC.
- Description
- Pharmaceutical Company
- Location
- New Jersey · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Budget reconciliation and President Bidens FY 2022 Budget Proposal, The American Jobs Plan, and The American Families Plan.
LobbyistsGEORGE OLSEN · NICOLE MARIE RUZINSKI BERTSCH
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Matters affecting access to and payment for pharmaceuticals under Medicare; Medicare coverage and payment for home infusion of drugs during the COVID-19 pandemic public health emergency. Legislation concerning Medicare prescription drug rebate reform, the 340B drug discount program, Buy America requirements, drug importation, and imposition of most favored nation pricing on drugs under Medicare Parts B and D; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and subsequent proposals; H.R. 19, Lower Costs, More Cures Act of 2021; and H.R. 5376, the Build Back Better Act.
LobbyistsGEORGE OLSEN · KARINA LYNCH · mr DAVID A STARR · CHERYL LYNN JAEGER · NICOLE MARIE RUZINSKI BERTSCH
Covered position (KARINA LYNCH): Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs
Covered position (CHERYL LYNN JAEGER): Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox
TargetedSENATE · HOUSE OF REPRESENTATIVES
